The CHARM programme.
Publication
, Journal Article
Pechlaner, C
Published in: Lancet
November 15, 2003
Duke Scholars
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
November 15, 2003
Volume
362
Issue
9396
Start / End Page
1675 / 1676
Location
England
Related Subject Headings
- Treatment Outcome
- Tetrazoles
- Risk
- Morbidity
- Humans
- Heart Failure
- General & Internal Medicine
- Cause of Death
- Biphenyl Compounds
- Benzimidazoles
Citation
APA
Chicago
ICMJE
MLA
NLM
Pechlaner, C. (2003). The CHARM programme. Lancet, 362(9396), 1675–1676. https://doi.org/10.1016/S0140-6736(03)14808-8
Pechlaner, Christoph. “The CHARM programme.” Lancet 362, no. 9396 (November 15, 2003): 1675–76. https://doi.org/10.1016/S0140-6736(03)14808-8.
Pechlaner C. The CHARM programme. Lancet. 2003 Nov 15;362(9396):1675–6.
Pechlaner, Christoph. “The CHARM programme.” Lancet, vol. 362, no. 9396, Nov. 2003, pp. 1675–76. Pubmed, doi:10.1016/S0140-6736(03)14808-8.
Pechlaner C. The CHARM programme. Lancet. 2003 Nov 15;362(9396):1675–1676.
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
November 15, 2003
Volume
362
Issue
9396
Start / End Page
1675 / 1676
Location
England
Related Subject Headings
- Treatment Outcome
- Tetrazoles
- Risk
- Morbidity
- Humans
- Heart Failure
- General & Internal Medicine
- Cause of Death
- Biphenyl Compounds
- Benzimidazoles